;

Auto Summaries - Diagnostics
Last updated: 2025 Jul 18
Total hit(s): 22979
S.No.
1
40553800
Letter to the editor: "Heart failure and co-morbidities confer a negative prognosis in COVID-19 infection".
N/A
Int J Cardiol
2025 Oct 15
2.3
1
2
40605610
Can the effects of the COVID-19 pandemic provide insights into the impact of melanoma under-diagnosis and delayed care?
N/A
Br J Dermatol
2025 Jul 3
6.22
1
3
40674101
COVID-19 Pandemic and Posttreatment Breast Cancer Surveillance and Outcomes.
N/A
JAMA Oncol
2025 Jul 17
13.86
1
4
40637948
Correction: Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2.
N/A
Mol Biol Rep
2025 Jul 10
2.19
1
5
40578525
Reply to letter to the editor: "Heart failure and co-morbidities confer a negative prognosis in COVID-19 infection", by Dr. Mehta and Dr. Sah.
N/A
Int J Cardiol
2025 Jun 25
2.3
1
6
40187968
A modified cut-off index for the Elecsys Anti-SARS-CoV-2 nucleocapsid electrochemiluminescence immunoassay.
N/A
Pathology
2025 Jun
3.744
1
7
40490390
Preventing COVID-19 in Correctional Facilities: The Impact of Rapid Antigen Tests on Early Detection and Infection Control.
N/A
Infect Chemother
2025 May 22
1.94
1
8
40405267
Retraction Note: Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing.
N/A
Gut Pathog
2025 May 22
1
9
40382391
Retraction Note: A non-enzymatic, isothermal strand displacement and amplification assay for rapid detection of SARS-CoV-2 RNA.
N/A
Nat Commun
2025 May 17
11.8
1
10
40381079
Retraction Note: COVID-19 diagnostic methods in developing countries.
N/A
Environ Sci Pollut Res Int
2025 May 17
1
11
40374074
Bridging the evidence gap: expert consensus on management of SARS-CoV-2 acute infection and post-COVID-19 condition in immunocompromised patients.
N/A
Clin Microbiol Infect
2025 May 13
6.17
1
12
40296406
Forty-steps desaturation test does not have prognostic value in COVID-19 due to omicron variant.
N/A
Lung India
2025 May 1
0.93
1
13
40260759
Gender Equity in Oral Pathology/Medicine: Analysis of Scientific Output Before and During COVID-19.
N/A
Oral Dis
2025 Apr 22
2.43
1
14
40244474
Correction to: Pediatric and adult patients with ME/CFS following COVID-19: A structured approach to diagnosis using the Munich Berlin Symptom Questionnaire (MBSQ).
N/A
Eur J Pediatr
2025 Apr 17
2.24
1
15
40122247
Rapid spread of Candida auris in China after COVID-19.
N/A
J Infect
2025 Apr
5.1
1
16
39965480
COVID-19 study quantifying daily viral loads confirms throat samples are key to early diagnosis.
N/A
Diagn Microbiol Infect Dis
2025 Apr
2.33
1
17
40147588
An overview of data analysis approaches and biases in unveiling the impact of COVID 19 on melanoma diagnosis.
N/A
J Invest Dermatol
2025 Mar 25
1
18
40113576
SARS-CoV-2 seroprevalence and associated risk factors in adult outpatients from Western Romania.
N/A
Infect Dis (Lond)
2025 Mar 20
1.23
1
19
40056872
Cerebello-brainstem dominant form of adrenoleukodystrophy with neurological symptom onset triggered by COVID-19.
N/A
J Neurol Sci
2025 Mar 2
2.69
1
20
40078101
Sandwich-type graphene electrochemical sensor for nucleic acid detection of SARS-CoV-2.
N/A
Acta Biochim Biophys Sin (Shanghai)
2025 Mar 12
1.96
1
21
39915267
Using SARS-CoV-2 nucleoprotein antibodies to detect (re)infection.
N/A
Epidemiol Infect
2025 Feb 7
2.01
1
22
39902844
A Case of Post-Acute Severe Acute Respiratory Syndrome Coronavirus 2-Induced Focal Nonconvulsive Status Epilepticus With Impairment of Consciousness Initially Diagnosed as Anxiety.
N/A
Clin Neuropharmacol
2025 Feb 5
1
23
40001344
Melanoma Diagnosis in the Post-COVID-19 Era: Return to "Normality" only in 2023 in 2 German Skin Tumour Centers.
N/A
Acta Derm Venereol
2025 Feb 25
3.01
1
24
39987727
Retraction notice to "Differential detection of SARS-CoV-2 variants and influenza A viruses utilizing a dual lateral flow strip based on colloidal gold-labeled monoclonal antibodies" [Int. J. Biol. Macromol. 280P4 (2024) 136067].
N/A
Int J Biol Macromol
2025 Feb 21
4.94
1
25
39401794
Combination Seasonal Vaccines for Influenza, Respiratory Syncytial Virus, Severe Acute Respiratory Syndrome Coronavirus 2, and Other Pathogens.
N/A
J Infect Dis
2025 Feb 20
4.73
1